ReviewCurrent rheumatology reports2013
Osteopenia: debates and dilemmas.
Review in Current rheumatology reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 28 citations in OpenAlex.
- Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.Journal of functional morphology and kinesiology · 2025Article
- Multidisciplinary consensus on the management of patients with osteopenia and fracture risk in Spain.BMC musculoskeletal disorders · 2025Article
- A 0.2 T-0.4 T Static Magnetic Field Improves the Bone Quality of Mice Subjected to Hindlimb Unloading and Reloading Through the Dual Regulation of BMSCs via Iron Metabolism.International journal of molecular sciences · 2024Article
- Bone Health Optimization in Adult Spinal Deformity Patients: A Narrative Review.Journal of clinical medicine · 2024Review
- Hemoglobin is associated with BMDs and risk of the 10-year probability of fractures in patients with type 2 diabetes mellitus.Frontiers in endocrinology · 2024Article
- Influencing factors of bone mass abnormalities among postmenopausal women in Tibet, China.BMC public health · 2023Article
- Toxoplasma gondii infection as a risk factor for osteoporosis: a case-control study.Parasites & vectors · 2022Article
- Physicians' Attitudes on Management of Osteopenia in South Korea.Journal of bone metabolism · 2020Article
- Article
- Transcriptomic profiling of tantalum metal implant osseointegration in osteopenic patients.BDJ open · 2018Article
- Effects of weight training time on bone mineral density of patients with secondary osteoporosis after hemiplegia.Experimental and therapeutic medicine · 2017Article
- Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients.Journal of neurology, neurosurgery, and psychiatry · 2016Article
- Association between Homocysteine and Bone Mineral Density according to Age and Sex in Healthy Adults.Journal of bone metabolism · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Whether or not to use pharmacologic agents for primary prevention of fracture among elderly men and women with osteopenia is debated by clinicians. In this review we provide an update to enable better understanding and characterization of this population, including the prevalence of osteopenia, transitioning from osteopenia to osteoporosis, and clinically applicable tools for fracture risk assessment. We also emphasize the very limited evidence of the benefits and risks of anti-osteoporotic agents for this population for primary fracture prevention, and the need for future studies to guide clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.